Lutetium Lu 177 Dotatate + Octreotide Acetate Interaction
Contraindicatedinteraction on record
Description
Octreotide competitively binds somatostatin receptors and may interfere with lutetium Lu 177 dotatate efficacy. Discontinue octreotide at least 24 hours prior to each lutetium dose.
Mechanism
Competitive binding to somatostatin receptors
Source: NLP:octreotide acetate